Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Assets (2019 - 2025)

Historic Assets for IDEAYA Biosciences (IDYA) over the last 7 years, with Q3 2025 value amounting to $1.2 billion.

  • IDEAYA Biosciences' Assets fell 441.47% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 441.47%. This contributed to the annual value of $1.1 billion for FY2024, which is 7311.93% up from last year.
  • According to the latest figures from Q3 2025, IDEAYA Biosciences' Assets is $1.2 billion, which was down 441.47% from $1.0 billion recorded in Q2 2025.
  • In the past 5 years, IDEAYA Biosciences' Assets ranged from a high of $1.2 billion in Q3 2024 and a low of $326.1 million during Q1 2021
  • For the 5-year period, IDEAYA Biosciences' Assets averaged around $664.8 million, with its median value being $527.6 million (2023).
  • Its Assets has fluctuated over the past 5 years, first soared by 22035.94% in 2021, then tumbled by 441.47% in 2025.
  • Over the past 5 years, IDEAYA Biosciences' Assets (Quarter) stood at $381.3 million in 2021, then rose by 1.74% to $388.0 million in 2022, then skyrocketed by 67.36% to $649.3 million in 2023, then surged by 73.12% to $1.1 billion in 2024, then grew by 5.43% to $1.2 billion in 2025.
  • Its last three reported values are $1.2 billion in Q3 2025, $1.0 billion for Q2 2025, and $1.1 billion during Q1 2025.